|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Biological process
|
oxidation-reduction process
|
2 terms
|
 |
|
Biochemical function
|
oxidoreductase activity
|
2 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Proc Natl Acad Sci U S A
101:8918-8923
(2004)
|
|
PubMed id:
|
|
|
|
|
| |
|
The crystal structure of activated protein C-inactivated bovine factor Va: Implications for cofactor function.
|
|
T.E.Adams,
M.F.Hockin,
K.G.Mann,
S.J.Everse.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
In vertebrate hemostasis, factor Va serves as the cofactor in the prothrombinase
complex that results in a 300,000-fold increase in the rate of thrombin
generation compared with factor Xa alone. Structurally, little is known about
the mechanism by which factor Va alters catalysis within this complex. Here, we
report a crystal structure of protein C inactivated factor Va (A1.A3-C1-C2) that
depicts a previously uncharacterized domain arrangement. This orientation has
implications for binding to membranes essential for function. A high-affinity
calcium-binding site and a copper-binding site have both been identified.
Surprisingly, neither shows a direct involvement in chain association. This
structure represents the largest physiologically relevant fragment of factor Va
solved to date and provides a new scaffold for the future generation of models
of coagulation cofactors.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
Fig. 3. Stereo images of the metal-binding sites in factor
Va[i]. (A) The copper-binding site in the A3 domain (blue) with
anomalous density for the copper is shown at 3 . The
trigonal planar coordination geometry is shown with dashed
lines. Nearby residues from the A1 domain (backbone shaded red)
are shown, and the distance to the closest residue is shown in
red. (B) The octahedral coordination geometry (dashed lines) of
the calcium-binding site in the A1 domain (red).
|
 |
Figure 4.
Fig. 4. Potential C domain membrane interactions. (A) The
membrane-binding spikes of the C1 (Left) and C2 (Right) domains.
The domains are displayed in similar orientations with respect
to the overall -barrel fold. Residues
potentially involved in membrane binding are shown. (B) Packing
interactions of the tryptophans from spike C2-1 (2050 and 2051)
with a hydrophobic pocket in the A3 domain (white, hydrophobic;
blue, polar) from a neighboring molecule.
|
 |
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
C.Costa,
C.Cavalcante,
F.Zito,
Y.Yokota,
and
V.Matranga
(2010).
Phylogenetic analysis and homology modelling of Paracentrotus lividus nectin.
|
| |
Mol Divers, 14,
653-665.
|
 |
|
|
|
|
 |
D.Venkateswarlu
(2010).
Structural investigation of zymogenic and activated forms of human blood coagulation factor VIII: a computational molecular dynamics study.
|
| |
BMC Struct Biol, 10,
7.
|
 |
|
|
|
|
 |
J.Hirbawi,
J.L.Vaughn,
M.A.Bukys,
H.L.Vos,
and
M.Kalafatis
(2010).
Contribution of amino acid region 659-663 of Factor Va heavy chain to the activity of factor Xa within prothrombinase .
|
| |
Biochemistry, 49,
8520-8534.
|
 |
|
|
|
|
 |
M.H.Bos,
and
R.M.Camire
(2010).
Procoagulant Adaptation of a Blood Coagulation Prothrombinase-like Enzyme Complex in Australian Elapid Venom.
|
| |
Toxins (Basel), 2,
1554-1567.
|
 |
|
|
|
|
 |
S.Kalkhof,
S.Haehn,
M.Paulsson,
N.Smyth,
J.Meiler,
and
A.Sinz
(2010).
Computational modeling of laminin N-terminal domains using sparse distance constraints from disulfide bonds and chemical cross-linking.
|
| |
Proteins, 78,
3409-3427.
|
 |
|
|
|
|
 |
Y.V.Sergeev,
R.C.Caruso,
M.R.Meltzer,
N.Smaoui,
I.M.MacDonald,
and
P.A.Sieving
(2010).
Molecular modeling of retinoschisin with functional analysis of pathogenic mutations from human X-linked retinoschisis.
|
| |
Hum Mol Genet, 19,
1302-1313.
|
 |
|
|
|
|
 |
Z.Liu,
L.Lin,
C.Yuan,
G.A.Nicolaes,
L.Chen,
E.J.Meehan,
B.Furie,
B.Furie,
and
M.Huang
(2010).
Trp2313-His2315 of factor VIII C2 domain is involved in membrane binding: structure of a complex between the C2 domain and an inhibitor of membrane binding.
|
| |
J Biol Chem, 285,
8824-8829.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Markoff,
V.Gerke,
and
N.Bogdanova
(2009).
Combined homology modelling and evolutionary significance evaluation of missense mutations in blood clotting factor VIII to highlight aspects of structure and function.
|
| |
Haemophilia, 15,
932-941.
|
 |
|
|
|
|
 |
D.Delev,
A.Pavlova,
S.Heinz,
E.Seifried,
and
J.Oldenburg
(2009).
Factor 5 mutation profile in German patients with homozygous and heterozygous factor V deficiency.
|
| |
Haemophilia, 15,
1143-1153.
|
 |
|
|
|
|
 |
J.Song,
K.Talbot,
J.Hewitt,
R.T.MacGillivray,
and
E.L.Pryzdial
(2009).
Differential contributions of Glu96, Asp102 and Asp111 to coagulation Factor V/Va metal ion binding and subunit stability.
|
| |
Biochem J, 422,
257-264.
|
 |
|
|
|
|
 |
S.Kanaji,
T.Kanaji,
M.Honda,
S.Nakazato,
K.Wakayama,
Y.Tabata,
S.Shibata,
H.Gondo,
I.Nakamura,
K.Node,
M.Miura,
M.Miyahara,
T.Okamura,
F.Nagumo,
S.Ohta,
and
K.Izuhara
(2009).
Identification of four novel mutations in F5 associated with congenital factor V deficiency.
|
| |
Int J Hematol, 89,
71-75.
|
 |
|
|
|
|
 |
S.Wu,
C.J.Lee,
and
L.G.Pedersen
(2009).
Conformational change path between closed and open forms of C2 domain of coagulation factor V on a two-dimensional free-energy surface.
|
| |
Phys Rev E Stat Nonlin Soft Matter Phys, 79,
041909.
|
 |
|
|
|
|
 |
A.Venceslá,
M.A.Corral-Rodríguez,
M.Baena,
M.Cornet,
M.Domènech,
M.Baiget,
P.Fuentes-Prior,
and
E.F.Tizzano
(2008).
Identification of 31 novel mutations in the F8 gene in Spanish hemophilia A patients: structural analysis of 20 missense mutations suggests new intermolecular binding sites.
|
| |
Blood, 111,
3468-3478.
|
 |
|
|
|
|
 |
B.W.Shen,
P.C.Spiegel,
C.H.Chang,
J.W.Huh,
J.S.Lee,
J.Kim,
Y.H.Kim,
and
B.L.Stoddard
(2008).
The tertiary structure and domain organization of coagulation factor VIII.
|
| |
Blood, 111,
1240-1247.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.C.Ngo,
M.Huang,
D.A.Roth,
B.C.Furie,
and
B.Furie
(2008).
Crystal structure of human factor VIII: implications for the formation of the factor IXa-factor VIIIa complex.
|
| |
Structure, 16,
597-606.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
J.Hirbawi,
M.A.Bukys,
M.A.Barhoover,
E.Erdogan,
and
M.Kalafatis
(2008).
Role of the acidic hirudin-like COOH-terminal amino acid region of factor Va heavy chain in the enhanced function of prothrombinase.
|
| |
Biochemistry, 47,
7963-7974.
|
 |
|
|
|
|
 |
M.A.Barhoover,
T.Orban,
D.O.Beck,
M.A.Bukys,
and
M.Kalafatis
(2008).
Contribution of amino acid region 334-335 from factor Va heavy chain to the catalytic efficiency of prothrombinase.
|
| |
Biochemistry, 47,
6840-6850.
|
 |
|
|
|
|
 |
M.A.Barhoover,
T.Orban,
M.A.Bukys,
and
M.Kalafatis
(2008).
Cooperative regulation of the activity of factor Xa within prothrombinase by discrete amino acid regions from factor Va heavy chain.
|
| |
Biochemistry, 47,
12835-12843.
|
 |
|
|
|
|
 |
M.Takeyama,
K.Nogami,
M.Okuda,
Y.Sakurai,
T.Matsumoto,
I.Tanaka,
A.Yoshioka,
and
M.Shima
(2008).
Selective factor VIII and V inactivation by iminodiacetate ion exchange resin through metal ion adsorption.
|
| |
Br J Haematol, 142,
962-970.
|
 |
|
|
|
|
 |
R.Majumder,
M.A.Quinn-Allen,
W.H.Kane,
and
B.R.Lentz
(2008).
A phosphatidylserine binding site in factor Va C1 domain regulates both assembly and activity of the prothrombinase complex.
|
| |
Blood, 112,
2795-2802.
|
 |
|
|
|
|
 |
S.B.Jeimy,
M.A.Quinn-Allen,
N.Fuller,
W.H.Kane,
and
C.P.Hayward
(2008).
Location of the multimerin 1 binding site in coagulation factor V: an update.
|
| |
Thromb Res, 123,
352-354.
|
 |
|
|
|
|
 |
T.C.Hsu,
K.P.Pratt,
and
A.R.Thompson
(2008).
The factor VIII C1 domain contributes to platelet binding.
|
| |
Blood, 111,
200-208.
|
 |
|
|
|
|
 |
Y.Z.Ohkubo,
and
E.Tajkhorshid
(2008).
Distinct structural and adhesive roles of Ca2+ in membrane binding of blood coagulation factors.
|
| |
Structure, 16,
72-81.
|
 |
|
|
|
|
 |
E.T.Parker,
and
P.Lollar
(2007).
Contribution of A1 subunit residue Q316 in thrombin-activated factor VIII to A2 subunit dissociation.
|
| |
Biochemistry, 46,
9737-9742.
|
 |
|
|
|
|
 |
I.Bento,
C.Peixoto,
V.N.Zaitsev,
and
P.F.Lindley
(2007).
Ceruloplasmin revisited: structural and functional roles of various metal cation-binding sites.
|
| |
Acta Crystallogr D Biol Crystallogr, 63,
240-248.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
K.Shinozawa,
K.Amano,
T.Suzuki,
A.Tanaka,
K.Iijima,
H.Takahashi,
H.Inaba,
and
K.Fukutake
(2007).
Molecular Characterization of 3 Factor V mutations, R2174L, V1813M, and a 5-bp Deletion, That Cause Factor V Deficiency.
|
| |
Int J Hematol, 86,
407-413.
|
 |
|
|
|
|
 |
L.Lin,
Q.Huai,
M.Huang,
B.Furie,
and
B.C.Furie
(2007).
Crystal structure of the bovine lactadherin C2 domain, a membrane binding motif, shows similarity to the C2 domains of factor V and factor VIII.
|
| |
J Mol Biol, 371,
717-724.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
L.Autin,
M.Steen,
B.Dahlbäck,
and
B.O.Villoutreix
(2006).
Proposed structural models of the prothrombinase (FXa-FVa) complex.
|
| |
Proteins, 63,
440-450.
|
 |
|
|
|
|
 |
L.Mollica,
F.Fraternali,
and
G.Musco
(2006).
Interactions of the C2 domain of human factor V with a model membrane.
|
| |
Proteins, 64,
363-375.
|
 |
|
|
|
|
 |
R.Asselta,
M.L.Tenchini,
and
S.Duga
(2006).
Inherited defects of coagulation factor V: the hemorrhagic side.
|
| |
J Thromb Haemost, 4,
26-34.
|
 |
|
|
|
|
 |
A.E.Johnson
(2005).
Fluorescence approaches for determining protein conformations, interactions and mechanisms at membranes.
|
| |
Traffic, 6,
1078-1092.
|
 |
|
|
|
|
 |
J.Boekhorst,
B.Verbruggen,
J.M.Lavergne,
J.M.Costa,
S.C.Schoormans,
P.P.Brons,
M.G.van Kraaij,
I.R.Nováková,
and
W.L.van Heerde
(2005).
Thirteen novel mutations in the factor VIII gene in the Nijmegen haemophilia A patient population.
|
| |
Br J Haematol, 131,
109-117.
|
 |
|
|
|
|
 |
L.Autin,
M.A.Miteva,
W.H.Lee,
K.Mertens,
K.P.Radtke,
and
B.O.Villoutreix
(2005).
Molecular models of the procoagulant factor VIIIa-factor IXa complex.
|
| |
J Thromb Haemost, 3,
2044-2056.
|
 |
|
|
|
|
 |
M.Kalafatis
(2005).
Coagulation factor V: a plethora of anticoagulant molecules.
|
| |
Curr Opin Hematol, 12,
141-148.
|
 |
|
|
|
|
 |
R.Ramachandran,
R.K.Tweten,
and
A.E.Johnson
(2005).
The domains of a cholesterol-dependent cytolysin undergo a major FRET-detected rearrangement during pore formation.
|
| |
Proc Natl Acad Sci U S A, 102,
7139-7144.
|
 |
|
|
|
|
 |
W.Bode
(2005).
The structure of thrombin, a chameleon-like proteinase.
|
| |
J Thromb Haemost, 3,
2379-2388.
|
 |
|
|
|
|
 |
W.Peng,
M.A.Quinn-Allen,
and
W.H.Kane
(2005).
Mutation of hydrophobic residues in the factor Va C1 and C2 domains blocks membrane-dependent prothrombin activation.
|
| |
J Thromb Haemost, 3,
351-354.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|